Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Vor Biopharma (NASDAQ:VOR)

BOSTON, Mass., June 01, 2026 (GLOBE NEWSWIRE) -- Vor Bio (NASDAQ:VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases,...